Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139019 · ClinicalTrials.gov registry record · NA
Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 596
- Enrollment target
NCT03139019: Completed NA study, sponsored by University of Pennsylvania.
NCT03139019 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 596 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03139019, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 596 participants
- Enrollment target
Study Summary
The relative effectiveness of incentives based on process (e.g. medication adherence) vs. outcome (improvements in blood pressure) is unknown, leading to the key research question: Which approach is more effective? The incentive structure for this initiative is based on best practices in the use of process and outcome measures to address this fundamental question. A series of incentive designs will be conducted to examine the relative effectiveness of equivalent value incentives based on process (e.g. attending smoking cessation counseling sessions), outcomes (e.g. quitting smoking), or a combination of process and outcomes incentives (e.g. attending smoking cessation counseling sessions and quitting smoking). This will also provide an overarching framework for assessing the relative importance of process versus outcome incentives in different contexts and for different populations.
Primary Outcome
Number of completed education sessions in a16-week DPP program
Interventions
- BEHAVIORAL Process incentives
- BEHAVIORAL Outcome incentives
- BEHAVIORAL Process and Outcome incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 596 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT03139019 record still lists
NCT03139019 is an interventional study that assigns participants to a tested intervention. The registered 596 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 3 interventions - of which Process incentives is the first listed.
NCT03139019 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03139019 about?
NCT03139019 is a clinical study titled "Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention". The relative effectiveness of incentives based on process (e.g. medication adherence) vs. outcome (improvements in blood pressure) is unknown, leading to the key research question: Which approach is more effective? The incentive structure for this initiative is based on best practices in the use of ...
What is the current status of trial NCT03139019?
This trial is currently completed. It is a NA study. The enrollment target is 596 participants. The study started on 2014-06. Estimated completion is 2016-12.
What interventions are being tested in trial NCT03139019?
The interventions under investigation include: Process incentives (BEHAVIORAL), Outcome incentives (BEHAVIORAL), Process and Outcome incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT03139019?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03139019's enrollment target sits among peer trials
596 174th of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02138734 · 596 participants · Phase 1
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
- NCT06797245 · 596 participants · NA
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
- NCT07100080 · 596 participants · Phase 2
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- NCT05723198 · 595 participants · Phase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia